What is behind Athletic Recovery & Muscle
The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.
Mitochondrial energy (ATP) output. Evidence A — Human trial evidence.
PGC-1α — the master regulator of mitochondrial biogenesis, building new cellular powerplants and oxidative endurance. Evidence A — Human trial evidence.
Serum testosterone — the anabolic signal behind muscle, drive and libido in men. The evidence shows a finding that overturns the common story: suppression under stress is centrally mediated — the brain down-regulating the axis — 'despite intact gonadal capacity'. The organ is rarely the problem. Evidence A — Human trial evidence.
The adaptation, not the workout. Training is the stimulus; recovery is where the gain is actually made — and the window is governed by inflammation resolving on schedule, not by inflammation being absent. Evidence A — Human trial evidence.
Insulin-like growth factor-1 — the dermal-papilla growth factor that drives follicle proliferation and prolongs anagen (the active growth phase). Evidence A — Human trial evidence.
Evidence on these pathways
IGF-1 → Muscle Recovery. “IGF-1 also potentiates skeletal muscle regeneration via activation of skeletal muscle stem (satellite) cells, which may contribute to muscle hypertrophy and/or inhibit atrophy.” — Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 2020, vol 9(9), 1970. doi:10.3390/cells9091970
NF-κB → CD38 NADase. “Regulation of CD38 expression in HASM cells involves the transcription factor NF-κB, and glucocorticoids inhibit this expression through NF-κB-dependent and -independent mechanisms.” — Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone. Respiratory Research, 2008, vol 9, 26. doi:10.1186/1465-9921-9-26
NF-κB → COX-2 Induction. “Moreover, the nuclear factor kappa B (NF-κB) inhibitor BAY11‐7085 or the TLR4 neutralizing antibody markedly blocked PM2.5-induced IL-6 and COX-2 expression.” — PM2.5 exposure upregulates pro-inflammatory protein expression in human microglial cells via oxidant stress and TLR4/NF-κB pathway. Ecotoxicology and Environmental Safety, 2024, vol 277, article 116386. doi:10.1016/j.ecoenv.2024.116386
NF-κB → Kynurenine Pathway. “Treatment of vaccinated DCs with pharmacological NF-κB inhibitors ACHP or DHMEQ significantly inhibited IDO1 biosynthesis, suggesting a role for NF-κB signaling in vaccine up-regulation of dendritic cell IDO1.” — Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit—Proinsulin Vaccine. PLoS ONE, 2015, volume 10, e0118562. doi:10.1371/journal.pone.0118562
Formulas that act on these pathways
Acts on 4 of these pathways: NF-κB, Total Testosterone, Muscle Recovery, IGF-1.
Acts on 4 of these pathways: NF-κB, PGC-1α Biogenesis, Total Testosterone, Muscle Recovery.
Acts on 4 of these pathways: NF-κB, PGC-1α Biogenesis, Total Testosterone, Muscle Recovery.
Acts on 4 of these pathways: NF-κB, PGC-1α Biogenesis, Total Testosterone, Muscle Recovery.
Acts on 3 of these pathways: NF-κB, Total Testosterone, Muscle Recovery.
Acts on 3 of these pathways: NF-κB, PGC-1α Biogenesis, Total Testosterone.
What this page does not claim
This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Athletic Recovery & Muscle. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.